Neimeth International Pharmaceuticals Plc released its Q3 2022 Unaudited results for the period ended September 30th, 2022.
Key Highlights
- Revenue declined by 11.3% from N3.05bn to N2.70bn.
- Loss before tax stood at N109.66m
- Loss after tax stood at N109.66m
- Share Price Currently Stands at N1.38k